Original articleFatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis*
References (13)
- et al.
Coronary artery disease in an 18-year-old girl with pseudoxanthoma elasticum: Successful surgical therapy
Am J Cardiol
(1975) - et al.
The Sweet syndrome in children
J Pediatr
(1981) - et al.
Hereditary disorders of fibrous tissue
- et al.
Heart disease in infants, children and adolescents
- et al.
Occlusive fibroelastosis of coronary arteries in the newborn
Circulation
(1967) - et al.
Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patientsfrom North America with patients from Hawaii and Japan
Pediatrics
(1977)
Cited by (79)
Pediatric Neutrophilic Dermatoses
2024, Dermatologic ClinicsSweet Syndrome in the Pediatric Population
2022, Dermatologic ClinicsCitation Excerpt :Second-line therapies in children include indomethacin, cyclosporine, and dapsone.7 Dapsone is thought to be less effective in MASS50; however, it may be useful in treating evolving cutis laxa, as discussed previously.42,51 The addition of intravenous immunoglobulin (IVIG) to dapsone has been used in immunodeficient children who do not respond well to standard treatments.50
Sweet heart: A case of pregnancy-associated acute febrile neutrophilic dermatosis with myopericarditis
2015, JAAD Case ReportsCitation Excerpt :Cardiac sequelae are extremely rare.7,8 Cases of acquired cutis laxa leading to cardiac complications have been observed months to years after the initial presentation of Sweet syndrome in the pediatric population.9-11 There is only one previous case report, to our knowledge, of myopericarditis in an adult with Sweet syndrome.12
Pyoderma gangrenosum and neutrophilic aortitis preceding the development of rheumatoid arthritis
2015, Annales de Dermatologie et de VenereologieNeutrophilic dermatoses as systemic diseases
2014, Clinics in DermatologyHurwitz Clinical Pediatric Dermatology, Fouth Edition
2011, Hurwitz Clinical Pediatric Dermatology, Fouth Edition
- *
Supported by Grant HL 07605 from the National Institutes ofHealth, National Heart, Lung and Blood Institute.